https://doi.org/10.1038/s41467-018-03283-z
J
Jelmar Quist
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
218
Papers
981
Citations
16
h-index
18
i10-index
Jelmar Quist is an academic researcher from King's College London. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & BRCA gene mutations in cancer & Cancer Genomics and Diagnostics. The author has an h-index of 16, co-authored 186 publications.
ORCID: 0000-0003-3071-3776Papers by this author
worksIntegrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancer
2018 · Nature Communications · 56 citations
Functional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epithelium
2016 · Oncogene · 28 citations
https://doi.org/10.1038/onc.2016.342
Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication
2021 · npj Breast Cancer · 24 citations
https://doi.org/10.1038/s41523-021-00292-y
Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trial
2020 · Annals of Oncology · 20 citations
https://doi.org/10.1016/j.annonc.2020.10.475
PAK6 acts downstream of IQGAP3 to promote contractility in triple negative breast cancer cells
2024 · Cellular Signalling · 8 citations
https://doi.org/10.1016/j.cellsig.2024.111233
Metadata record for the article: Systemic immune reaction in axillary lymph nodes adds to tumor infiltrating lymphocytes in triple-negative breast cancer prognostication
2021 · Research Portal (King's College London) · 1 citations
https://doi.org/10.6084/m9.figshare.14589063
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat